Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics

13 noviembre 2014

The two U.S. FDA approved oligonucleotide-based drugs on the market both have a modified chemical backbone made of phosphorothioates. The therapeutic advantages of the phosphorothioate group …
http://www.physnews.com/bio-medicine-news/cluster1068244272/

Volver